Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures

Pediatrics

Volumn 118, Issue 2, 2006, Pages

  Trevathan, Edwin ^a   Kerls, Susan P ^b   Hammer, Anne E ^b   Vuong, Alain ^b   Messenheimer, John A ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Childhood epilepsy; Clinical trial; Generalized tonic clonic seizures; Juvenile myoclonic epilepsy; Lamotrigine

Indexed keywords

ANTICONVULSIVE AGENT; LAMOTRIGINE; PLACEBO; TRIAZINE DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; DISORIENTATION; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; FEMALE; HEADACHE; HUMAN; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MYOCLONUS; MYOCLONUS SEIZURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RHINOPHARYNGITIS; SPIKE WAVE; TONIC CLONIC SEIZURE; TREATMENT DURATION; ABSENCE; COMPARATIVE STUDY; DRUG ADMINISTRATION; DRUG COMBINATION; GENERALIZED EPILEPSY; GRAND MAL EPILEPSY; MYOCLONUS EPILEPSY; PRESCHOOL CHILD; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EPILEPSIES, MYOCLONIC; EPILEPSY, ABSENCE; EPILEPSY, GENERALIZED; EPILEPSY, TONIC-CLONIC; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAZINES;

EID: 33845985661     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-0148     Document Type: Article

References (29)

1. Murphy CC, Trevathan E, Yeargin-Allsopp M. Prevalence of epilepsy and epileptic seizures in 10-year-old children: results from the Metropolitan Atlanta Developmental Disabilities Study. Epilepsia. 1995;36:866-872
2. Zarrelli MM, Beghi E, Rocca WA, Hauser WA. Incidence of epileptic syndromes in Rochester, Minnesota: 1980-1984. Epilepsia. 1999;40:1708-1714
3. Buck D, Baker GA, Jacoby A, Smith DF, Chadwick DW. Patients' experiences of injury as a result of epilepsy. Epilepsia. 1997;38:439-444
4. Forsgren L, Hauser WA, Olafsson E, Sander JW, Sillanpää M, Tomson T. Mortality of epilepsy in developed countries: a review. Epilepsia. 2005;46(suppl 11):18-27
5. Duchowny M, Pellock JM, Graf WD, et al. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Neurology. 1999;53:1724-1731
6. Coppola G, Auricchio G, Federico R, Carotenuto M, Pascotto A. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. Epilepsia. 2004;45:1049-1053
7. Frank LM, Enlow T, Holmes GL, et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia. 1999;40:973-979
8. Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, Manasco P. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group [published correction appears in N Engl J Med. 1998;1339:1851-1802]. N Engl J Med. 1997;337:1807-1812
9. Mikati MA, Holmes GL. Lamotrigine in absence and primary generalized epilepsies. J Child Neurol. 1997;12(suppl 1):S29-S37
10. Gericke CA, Picard F, de Saint-Martin A, Strumia S, Marescaux C, Hirsch E. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study. Epileptic Disord. 1999;1:159-165
11. Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group [published correction appears in Lancet. 1995;1345:1662]. Lancet. 1995;345:476-479
12. Steiner TJ, Dellaportas CI, Findley LJ, et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia. 1999;40:601-607
13. Brodie MJ, Chadwick DW, Anhut H, et al. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia. 2002;43:993-1000
14. Biton V, Sackellares JC, Vuong A, Hammer AE, Barrett PS, Messenheimer JA. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures. Neurology. 2005;65:1737-1743
15. Lerman-Sagie T, Lerman P. Dramatic effect of lamotrigine in young adults suffering from intractable absences and generalized tonic-clonic seizures since childhood. J Epilepsy. 1998;11:148-151
16. Kochen S, Giagante B, Oddo S. Spike-and-wave complexes and seizure exacerbation caused by carbamazepine. Eur J Neurol. 2002;9:41-47
17. Snead OC 3rd, Hosey LC. Exacerbation of seizures in children by carbamazepine. N Engl J Med. 1985;313:916-921
18. Sazgar M, Bourgeois BF. Aggravation of epilepsy by antiepileptic drugs. Pediatr Neurol. 2005;33:227-234
19. The Group for the evaluation of cinromide in the Lennox-Gastaut syndrome. Double-blind, placebo-controlled evaluation of cinromide in patients with the Lennox-Gastaut syndrome. Epilepsia. 1989;30:422-429
20. Biton V, Montouris GD, Ritter F, et. al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Neurology. 1999;52:1330-1337
21. Chadwick D, Leiderman DB, Sauermann W, et. al. Gabapentin in generalized seizures. Epilepsy Res. 1996:191-197
22. Sillanpaa M, Jalava M, Kaleva O, Shinnar S. Long-term prognosis of seizures with onset in childhood. N Engl J Med. 1998;338:1715-1722
23. Pellock JM, Wilder BJ, Deaton R, Sommerville KW. Acute pancreatitis coincident with valproate use: a critical review. Epilepsia. 2002;43:1421-1424
24. Biton V, Mirza W, Montouris GD, Vuong A, Hammer AE, Barrett PS. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology. 2001;2001:172-177
25. Nelson-DeGrave VL, Wickenheisser JK, Cockrell JE, et al. Valproate potentiates androgen biosynthesis in human ovarian theca cells. Endocrinology. 2004;145:799-808
26. Gross-Tsur V, Shalev RS. Reversible language regression as an adverse effect of topiramate treatment in children. Neurology. 2004;62:299-300
27. Messenheimer JA. Rash in adult and pediatric patients treated with lamotrigine. Can J Neurol Sci. 1998;25:S14-S18
28. Guberman AH, Besag FM, Brodie MJ, et al. Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia. 1999;40:985-991
29. Crespel A, Genton P, Berramdane M, et al. Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies. Neurology. 2005;65:762-764